Real-World Clinical Outcomes in Asthmatic Patients Switched from Omalizumab to Anti-Interleukin-5 Therapy
J Asthma Allergy
.
2022 Jul 11:15:935-937.
doi: 10.2147/JAA.S358321.
eCollection 2022.
Authors
Emily O'Reilly
1
,
Deborah Casey
1
,
Hisham Ibrahim
1
,
Alice McGrath
1
,
Tomás McHugh
1
,
Punitha Vairamani
1
,
Jill Murphy
1
,
Barry Plant
1
2
,
Desmond M Murphy
1
2
Affiliations
1
Department of Respiratory Medicine, Cork University Hospital, Cork, Ireland.
2
Health Research Board Clinical Research Facility, University College Cork, Cork, Ireland.
PMID:
35844776
PMCID:
PMC9285523
DOI:
10.2147/JAA.S358321
No abstract available